Millennials, Gen X are at elevated risk of developing cancer than older generations
HQ Team August 2, 2024:Cancer risk is higher among the younger generation than the older ones, according to a new study. Millennials and.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 2, 2024:Cancer risk is higher among the younger generation than the older ones, according to a new study. Millennials and.
French drugmaker Sanofi SA will build a 1.3 billion euro ($1.4 billion) insulin manufacturing facility in Germany’s Frankfurt to secure the long-term supply.
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.
The US Food and Drug Administration has approved the Darzalex Faspro combination drug therapy of Janssen Research and Development for treating blood cancer.
HQ Team July 31, 2024: A new research published in the Annals of Internal Medicine reveals that semaglutide is effective in helping people quit.
A survey from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) shows that nearly a third of American adolescents and teens received.
An eye scan can spot early signs of Alzheimer’s disease in the retina or the small blood vessels in the back of the.
The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely.
About 24% of adolescent girls or close to 19 million globally have experienced physical or sexual violence by their intimate partner by the.
Daiichi Sankyo and AstraZeneca’s breast cancer treatment ran into opposition from the UK’s healthcare spending watchdog, which wants Enhertu drug to be offered.